Description
RGDS is a tetrapeptide that delivers attached compounds to targets such as thrombus or tumor cells; it enhances efficacy of anticancer and anti-aggregation or anti-adhesion compounds. RDGS binds integrins on the surfaces of cells. RGDS also exhibits anti-inflammatory benefit, improving ventilation-induced lung injury by preventing activation of NF-κB and suppressing production of TNF-α and IL-6 in vivo.